Nevertheless, Kitamoto et al. [39] described lower PNPLA3 mRNA levels in the liver of patients with an advanced grade of NAFLD (with fibrosis) compared with those with mild NAFLD. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.